| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 01/12/2012 | US20120010238 Deuterated n-ethyl-n-phenyl-1,2-dihydro-4-hydroxy-5-chloro-1-methyl-2-oxoquinoline-3-carboxamide, salts and uses thereof |
| 01/12/2012 | US20120010218 Formulations |
| 01/12/2012 | US20120010217 Non-sedating antihistamine injection formulations and methods of use thereof |
| 01/12/2012 | US20120010214 3-(IMIDAZOLYL)-PYRAZOLO[3,4-b]PYRIDINES |
| 01/12/2012 | US20120010197 Protein kinase inhibitors |
| 01/12/2012 | US20120010191 Pyridone and aza-pyridone compounds and methods of use |
| 01/12/2012 | US20120010188 Imidazopyridine Compounds |
| 01/12/2012 | US20120010172 Novel urea and thiourea derivatives |
| 01/12/2012 | US20120010158 Tumor necrosis factor inhibiting peptides and uses thereof |
| 01/12/2012 | US20120010155 Gntiii expression in plants |
| 01/12/2012 | US20120010149 Peptide combination |
| 01/12/2012 | US20120010126 Recombinant surfactant protein d compositions and methods of use thereof |
| 01/12/2012 | US20120010124 Cell Penetrating Peptide Conjugates for Delivering of Nucleic Acids into a Cell |
| 01/12/2012 | US20120009648 DNA polymerase lambda and uses thereof |
| 01/12/2012 | US20120009248 Preservation of Bioactive Materials By Spray Drying |
| 01/12/2012 | US20120009247 Phospholipid drug analogs |
| 01/12/2012 | US20120009222 Modulation of the immune response |
| 01/12/2012 | US20120009221 Transfection of blood cells with mrna for immune stimulation and gene therapy |
| 01/12/2012 | US20120009220 Low Antigen-dose Immunization for Maximizing T-helper Cell 1 (Th1) Immunity Against a Pathogen |
| 01/12/2012 | US20120009219 Bacillus anthracis protective antigen sequences |
| 01/12/2012 | US20120009217 Monoparamunity inducers based on attenuated rabbit myxomaviruses |
| 01/12/2012 | US20120009216 Early detection of flaviviruses using the ns1 glycoprotein |
| 01/12/2012 | US20120009215 Influenza hemagglutinin and neuraminidase variants |
| 01/12/2012 | US20120009214 Intergenic regions as novel sites for insertion of hiv dna sequences in the genome of modified vaccinia virus ankara |
| 01/12/2012 | US20120009212 Conjugates utilizing platform technology for stimulating immune response |
| 01/12/2012 | US20120009211 Bimer or an oligomer of a dimer, trimer, quadromer or pentamer of recombinant fusion proteins |
| 01/12/2012 | US20120009210 Hypallergenic mosaic antigens and methods of making same |
| 01/12/2012 | US20120009208 USE OF MEMBRANE ATTACK COMPLEX (MAC) AND IMMUNE COMPLEXES (ICs) TO ACTIVATE T-CELLS AND THE GENERATION OF REGULATORY T CELLS |
| 01/12/2012 | US20120009207 Complete human monoclonal IgG4lambda specific for CTLA-4 and uses thereof for detection of soluble CTLA-4 and isolation of regulatory cells |
| 01/12/2012 | US20120009206 Novel double-stranded ribonucleic acids with rugged physico-chemical structure and highly specific biologic activity |
| 01/12/2012 | US20120009203 Depletion of cancer stem cells |
| 01/12/2012 | US20120009198 Compositions and Methods for Modulating Immune Response |
| 01/12/2012 | US20120009196 Monoclonal antibodies against hepatitis c virus core protein |
| 01/12/2012 | US20120009190 Identification and method for using the pre-ligand assembly domain of the il-17 receptor |
| 01/12/2012 | US20120009189 Antibody composition with altered fab sialylation |
| 01/12/2012 | US20120009188 Optimized fc variants |
| 01/12/2012 | US20120009187 Cloning and recombinant productions of vespula venom protease and methods of use thereof |
| 01/12/2012 | US20120009177 Gene expression markers for predicting response to interleukin-6 receptor-inhibiting monoclonal antibody drug treatment |
| 01/12/2012 | US20120009149 Tetrameric Cytokines with Improved Biological Activity |
| 01/12/2012 | US20120009140 Compostition and therapeutic anti-tumour vaccine |
| 01/12/2012 | US20120006716 Humanized anti-il-6 antibodies |
| 01/12/2012 | US20120006323 Nasal devices |
| 01/12/2012 | CA2840079A1 Compositions and methods for treating influenza |
| 01/12/2012 | CA2804986A1 Deuterated n-ethyl-n-phenyl-1,2-dihydro-4-hydroxy-5-chloro-1-methyl-2-oxoquinoline-3-carboxamide, salts and uses thereof |
| 01/12/2012 | CA2804918A1 N-hydroxyformamide derivative and medicament containing same |
| 01/12/2012 | CA2804666A1 Methods of immune modulation |
| 01/12/2012 | CA2804604A1 Designer peptide-based pcv2 vaccine |
| 01/12/2012 | CA2804473A1 5-(biphenyl-4-yl)-3-phenyl-1,2,4-oxadiazolyl derivatives as ligands on the sphingosine 1-phosphate (s1p) receptors |
| 01/12/2012 | CA2804127A1 Cancer peptide vaccine |
| 01/12/2012 | CA2804029A1 Ceramide-like glycolipid-associated bacterial vaccines and uses thereof |
| 01/12/2012 | CA2802807A1 Array of age-tailored nutritional formula with optimum fat content |
| 01/11/2012 | EP2405004A1 Recombinant vaccines against caligid copepods (sea lice) and antigen sequences thereof |
| 01/11/2012 | EP2405003A1 Recombinant vaccines against caligid copepods (sea lice) and antigen sequences thereof |
| 01/11/2012 | EP2404997A1 Method for enhancing function of t cell |
| 01/11/2012 | EP2404618A1 Immunomodulatory protein constructs with a helical polymeric backbone. |
| 01/11/2012 | EP2404603A1 Novel trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compounds for the treatment of CSBP/p38 kinase mediated diseases |
| 01/11/2012 | EP2404507A1 Array of age-tailored nutritional formula with optimum fat content |
| 01/11/2012 | EP2403871A1 Antibodies and epitopes specific to misfolded prion protein |
| 01/11/2012 | EP2403849A1 Oxazole pyridine derivatives useful as s1p1 receptor agonists |
| 01/11/2012 | EP2403539A2 Methods and systems for treatment and/or diagnosis |
| 01/11/2012 | EP2403529A1 Anti-rhesus d monoclonal antibody |
| 01/11/2012 | EP2403513A2 Fractions of wheat germ ferment |
| 01/11/2012 | EP1572074B1 Stabilized synthetic immunogen delivery system |
| 01/11/2012 | EP1565210B1 Clostridial neurotoxin for use in the treatment of nasal congestion |
| 01/11/2012 | EP1511845B1 Immunostimulatory oligonucleotides and uses thereof |
| 01/11/2012 | EP1483384B1 Method for overexpression of zwitterionic polysaccharides |
| 01/11/2012 | CN102317318A Anti-CD160 monoclonal antibodies and uses thereof |
| 01/11/2012 | CN102317282A Hetero ring derivative |
| 01/11/2012 | CN102317268A 2-biphenylamino-4-aminopyrimidine derivatives as kinase inhibitors |
| 01/11/2012 | CN102316878A Glycolipid mixture with antiinflammatory acivity obtained from oscillatoria planktothrix |
| 01/11/2012 | CN102316873A Compounds and methods for enhancing erythropoiesis |
| 01/11/2012 | CN102311986A Cells producing antibody compositions |
| 01/11/2012 | CN102311509A Extracting method of sweet potato stem leaf polysaccharide |
| 01/11/2012 | CN102311448A Thieno-pyrimidone DPP-IV (dipeptidyl peptidase) inhibitor |
| 01/11/2012 | CN102311447A Heterocyclo pyrimidone dipeptidyl peptidase-IV (DPP-IV) inhibitor |
| 01/11/2012 | CN102311396A Pyrazine derivative and preparation method as well as application thereof to pharmacy |
| 01/11/2012 | CN102311385A Novel 1-2-dihydroquinoline derivative having glucocorticoid receptor binding activity |
| 01/11/2012 | CN102311380A Piperidyl-4-carboxyl amide derivative and preparation method as well as application thereof |
| 01/11/2012 | CN102309767A Soluble osthole clathrate, dispersing tablet and preparation method thereof |
| 01/11/2012 | CN102309757A Novel regulatory factor of FOXP3 and regulatory T cells, and use thereof |
| 01/11/2012 | CN102309756A Compound medicament containing phosphodiesterase 4 inhibitor and glucocorticoid and used for treating dermatosis |
| 01/11/2012 | CN102309751A Superoxide dismutase (SOD) composite capsule and preparation method thereof |
| 01/11/2012 | CN102309727A Chinese patent medicine for facial beautification and longevity |
| 01/11/2012 | CN102309669A Chinese medicinal preparation for treating allergic conjunctivitis |
| 01/11/2012 | CN102309615A Small water turtle, ginseng and pilose antler wine |
| 01/11/2012 | CN102309604A Medicine for treating chronic urticaria and preparation method thereof |
| 01/11/2012 | CN102309573A Cytokine modulators and related method of use |
| 01/11/2012 | CN102309562A Preparation method of taste-masked suspension granules of Gegenqinlian decoction |
| 01/11/2012 | CN102309539A Spina gleditsiae extract hydrogel patch and preparation method thereof |
| 01/11/2012 | CN102309537A Anti-fatigue and immunity-enhancing Chinese medicinal composition, its preparation method and application |
| 01/11/2012 | CN102309527A Drug for controlling death stealing of Penaeus vannamei Boone and preparation method thereof |
| 01/11/2012 | CN102309494A Medicinal application of pristimerin as inflammatory cytokine inhibitor |
| 01/11/2012 | CN102309455A Dexamethasone sodium phosphate powder injection and production method thereof |
| 01/11/2012 | CN102309001A Food composition and medicinal composition of lactobacillus strain for treating allergy |
| 01/11/2012 | CN102308898A Medicinal fresh Chinese herb tea containing Chimonanthus fragrans, and preparation method and usage thereof |
| 01/11/2012 | CN102028812B Chinese medicinal preparation for treating allergic rhinitis, allergic asthma and urticaria and preparation method thereof |
| 01/11/2012 | CN101675922B Parakeratosis inhibitor, pore-shrinking agent and skin preparation for external use |
| 01/11/2012 | CN101548989B Mactra veneriformis extract, preparation method and application thereof |
| 01/11/2012 | CN101524374B Auricularia Polytricha(Mont)Sacl fermentation product, oral preparation containing same, preparation method and application |
| 01/11/2012 | CN101376910B Use of miRNA genes in systemic lupus erythematosus disease diagnose and treatment |